AAAAAA
Results: 1-25/58
Authors:
HUDSON JM
CASTILLEJA A
MURRAY JL
HONDA T
KUDELKA A
SINGLETARY E
WHARTON JT
IOANNIDES CG
Citation: Jm. Hudson et al., GROWTH AND ANTIGEN RECOGNITION OF TUMOR-INFILTRATING LYMPHOCYTES FROMHUMAN BREAST-CANCER, Journal of interferon & cytokine research, 18(7), 1998, pp. 529-536
Authors:
TUTTLE TM
ANDERSON BW
THOMPSON WE
LEE JE
SAHIN A
SMITH TL
GRABSTEIN KH
WHARTON JT
IOANNIDES CG
MURRAY JL
Citation: Tm. Tuttle et al., PROLIFERATIVE AND CYTOKINE RESPONSES TO CLASS-II HER-2 NEU-ASSOCIATEDPEPTIDES IN BREAST-CANCER PATIENTS/, Clinical cancer research, 4(8), 1998, pp. 2015-2024
Authors:
MITCHELL MF
TORTOLEROLUNA G
LEE JJ
HITTELMAN WN
LOTAN R
WHARTON JT
HONG WK
NISHIOKA K
Citation: Mf. Mitchell et al., PHASE-I DOSE DE-ESCALATION TRIAL OF ALPHA-DIFLUOROMETHYLORNITHINE IN PATIENTS WITH GRADE-3 CERVICAL INTRAEPITHELIAL NEOPLASIA, Clinical cancer research, 4(2), 1998, pp. 303-310
Authors:
MITCHELL MF
TORTOLEROLUNA G
LEE JJ
HITTELMAN WN
LOTAN R
WHARTON JT
HONG WK
NISHIOKA K
Citation: Mf. Mitchell et al., PHASE-I DOSE DE-ESCALATION TRIAL OF ALPHA-DIFLUOROMETHYLORNITHINE IN PATIENTS WITH GRADE-3 CERVICAL INTRAEPITHELIAL NEOPLASIA, Clinical cancer research, 4(2), 1998, pp. 303-310
Authors:
TORNOS C
SILVA EG
BURKE TW
WHARTON JT
GERSHENSON DM
Citation: C. Tornos et al., CLINICAL IMPACT OF 2ND-OPINION PATHOLOGY IN OVARIAN-TUMORS, Modern pathology, 11(1), 1998, pp. 116-116
Authors:
CASTILLEJA A
OBRIAN CA
ANDERSON BW
WHARTON JT
IOANNIDES CG
Citation: A. Castilleja et al., INHIBITION OF CTL EPITOPE PRESENTATION AND TUMOR IMMUNOGENICITY BY HER-2 TYROSINE PHOSPHORYLATION, The FASEB journal, 12(4), 1998, pp. 1684-1684
Authors:
GERSHENSON DM
BURKE TW
MORRIS M
BAST RC
GUASPARI A
HOHNEKER J
WHARTON JT
Citation: Dm. Gershenson et al., A PHASE-I STUDY OF A DAILY X3 SCHEDULE OF INTRAVENOUS VINORELBINE FORREFRACTORY EPITHELIAL OVARIAN-CANCER, Gynecologic oncology (Print), 70(3), 1998, pp. 404-409
Authors:
WHARTON JT
GERSHENSON DM
Citation: Jt. Wharton et Dm. Gershenson, IN-MEMORIAM - RUTLEDGE,FELIX,NOAH (1917-1997), Gynecologic oncology, 68(2), 1998, pp. 141-142
Authors:
AABO K
ADAMS M
ADNITT P
ALBERTS DS
ATHANAZZIOU A
BARLEY V
BELL DR
BIANCHI U
BOLIS G
BRADY MF
BRODOVSKY HS
BRUCKNER H
BUYSE M
CANETTA R
CHYLAK V
COHEN CJ
COLOMBO N
CONTE PF
CROWTHER D
EDMONSON JH
GENNATAS C
GILBEY E
GORE M
GUTHRIE D
KAYE SB
LAING AH
LANDONI F
LEONARD RC
LEWIS C
LIU PY
MANGIONI C
MARSONI S
MEERPOHL H
OMURA GA
PARMAR MKB
PATER J
PECORELLI S
PRESTI M
SAUERBREI W
SKARLOS DV
SMALLEY RV
SOLOMON HJ
STEWART LA
STURGEON JFG
TATTERSALL MHN
WHARTON JT
HUININK WWT
TOMIROTTI M
TORRI W
TROPE C
TURBOW MM
VERMORKEN JB
WEBB MJ
WILBUR DW
WILLIAMS CJ
WILTSHAW E
YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
Authors:
FISK B
DAGUE B
SEIFERT WE
KUDELKA AP
WHARTON JT
MURRAY JL
IOANNIDES CG
Citation: B. Fisk et al., MASS-SPECTROMETRIC ANALYSIS OF NATURALLY PROCESSED PEPTIDES RECOGNIZED BY OVARIAN TUMOR-ASSOCIATED CD8(+) CTL, International journal of oncology, 10(1), 1997, pp. 159-169
Authors:
MITCHELL MF
TORTOLEROLUNA G
LEE JJ
HITTELMAN WK
LOTAN R
WHARTON JT
HONG WK
NISHIOKA K
Citation: Mf. Mitchell et al., POLYAMINE MEASUREMENTS IN THE UTERINE CERVIX, Journal of cellular biochemistry, 1997, pp. 125-132
Authors:
FISK B
HUDSON M
KAVANAGH J
WHARTON JT
MURRAY JL
IOANNIDES CG
KUDELKA AP
Citation: B. Fisk et al., EXISTENT PROLIFERATIVE RESPONSES OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM HEALTHY DONORS AND OVARIAN-CANCER PATIENTS TO HER-2 PEPTIDES, Anticancer research, 17(1A), 1997, pp. 45-53
Authors:
TUTTLE TM
THOMPSON WE
ANDERSON BW
LEE JE
GRABSTEIN KW
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: Tm. Tuttle et al., HER-2 NEU PEPTIDE INDUCES TH1 RESPONSES IN ASSOCIATION WITH HLA-DR4 IN BREAST-CANCER PATIENTS/, Journal of allergy and clinical immunology, 99(1), 1997, pp. 188-188
Authors:
MUNKARAH AR
HALLUM AV
MORRIS M
BURKE TW
LEVENBACK C
ATKINSON EN
WHARTON JT
GERSHENSON DM
Citation: Ar. Munkarah et al., PROGNOSTIC-SIGNIFICANCE OF RESIDUAL DISEASE IN PATIENTS WITH STAGE-IVEPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 64(1), 1997, pp. 13-17
Authors:
FISK B
ANDERSON BW
GRAVITT KR
OBRIAN CA
KUDELKA AP
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: B. Fisk et al., IDENTIFICATION OF NATURALLY PROCESSED HUMAN OVARIAN PEPTIDES RECOGNIZED BY TUMOR-ASSOCIATED CD8(-LYMPHOCYTES() CYTOTOXIC T), Cancer research, 57(1), 1997, pp. 87-93
Authors:
IOANNIDES CG
FISK B
MELICHAR B
ANDERSON B
STIFANI S
PAPAYANNOPOULOS CG
MURRAY JL
KUDELKA A
WHARTON JT
Citation: Cg. Ioannides et al., OVARIAN AND BREAST CYTOTOXIC LYMPHOCYTES CAN RECOGNIZE PEPTIDES FROM THE AES PROTEIN OF THE NOTCH COMPLEX, The FASEB journal, 10(6), 1996, pp. 2519-2519
Authors:
FISK B
DAGUE B
SEIFERT WE
LAMBRIS JD
PAPAYANNOPOULOS I
KUDELKA A
WHARTON JT
IOANNIDES CG
Citation: B. Fisk et al., OVARIAN CYTOTOXIC T-LYMPHOCYTES CAN RECOGNIZE COMMON PEPTIDES PRESENTED BY HLA-A2+ TUMORS, The FASEB journal, 10(6), 1996, pp. 2707-2707
Authors:
MELICHAR B
HUDSON JM
HONDA T
TUTTLE T
MURRAY JL
WHARTON JT
IOANNIDES CG
Citation: B. Melichar et al., CHARACTERIZATION OF ANTIGEN RECOGNITION IN TUMOR-INFILTRATING LYMPHOCYTES IN BREAST-CANCER, The FASEB journal, 10(6), 1996, pp. 2713-2713
Authors:
WHARTON JT
TORTOLEROLUNA G
LINARES AC
MALPICA A
BAKER VV
COOK E
JOHNSON E
MITCHELL MF
Citation: Jt. Wharton et al., VAGINAL INTRAEPITHELIAL NEOPLASIA AND VAGINAL-CANCER, Obstetrics and gynecology clinics of North America, 23(2), 1996, pp. 325
Authors:
CHYLE V
ZAGARS GK
WHEELER JA
WHARTON JT
DELCLOS L
Citation: V. Chyle et al., DEFINITIVE RADIOTHERAPY FOR CARCINOMA OF THE VAGINA - OUTCOME AND PROGNOSTIC FACTORS, International journal of radiation oncology, biology, physics, 35(5), 1996, pp. 891-905
Authors:
LEVENBACK C
BURKE TW
RUBIN SC
CURTIN JP
WHARTON JT
Citation: C. Levenback et al., ARTERIAL-OCCLUSION COMPLICATING TREATMENT OF GYNECOLOGIC CANCER - A CASE SERIES, Gynecologic oncology, 63(1), 1996, pp. 40-46
Authors:
BURKE TW
LEVENBACK C
TORNOS C
MORRIS M
WHARTON JT
GERSHENSON DM
Citation: Tw. Burke et al., INTRAABDOMINAL LYMPHATIC MAPPING TO DIRECT SELECTIVE PELVIC AND PARAAORTIC LYMPHADENECTOMY IN WOMEN WITH HIGH-RISK ENDOMETRIAL CANCER - RESULTS OF A PILOT-STUDY, Gynecologic oncology, 62(2), 1996, pp. 169-173
Authors:
LEVENBACK C
MORRIS M
BURKE TW
GERSHENSON DM
WOLF JK
WHARTON JT
Citation: C. Levenback et al., GROIN DISSECTION PRACTICES AMONG GYNECOLOGIC ONCOLOGISTS TREATING EARLY VULVAR CANCER, Gynecologic oncology, 62(1), 1996, pp. 73-77
Authors:
WOLF JK
WHARTON JT
Citation: Jk. Wolf et Jt. Wharton, WILD-TYPE P53 OVEREXPRESSION - WHAT ROLE IN TUMORIGENESIS, Gynecologic oncology, 60(3), 1996, pp. 337-338
Authors:
GERSHENSON DM
MORRIS M
BURKE TW
LEVENBACK C
MATTHE CM
WHARTON JT
Citation: Dm. Gershenson et al., TREATMENT OF POOR-PROGNOSIS SEX CORD-STROMAL TUMORS OF THE OVARY WITHTHE COMBINATION OF BLEOMYCIN, ETOPOSIDE, AND CISPLATIN, Obstetrics and gynecology, 87(4), 1996, pp. 527-531